Clin2
NCT07002801Possibly a fitRecruiting

Remimazolam and Esketamine for Older Adults Having Painless Stomach and Colon Scope

Gastrointestinal Disease

Part of Digestive system clinical trials.

This trial tests a combination of two sedative medicines (Remimazolam and Esketamine) for elderly patients having a painless stomach and colon exam. The goal is to see if this combination is safe and effective for older adults.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
280 people
Ages
65 years and older
Study type
Interventional

Who can take part

  • You are 65 years or older.
  • You are having a painless stomach and/or colon scope exam (gastroscopy/colonoscopy) as an outpatient.
  • You are in overall good health (ASA grade I, II, or III).
  • You do not have serious liver or kidney problems.
  • You do not have uncontrolled high blood pressure or serious heart disease.
  • You are not currently taking certain medicines like strong sedatives, antidepressants, or antipsychotics.
  • You do not have a history of heavy smoking or alcohol addiction.
  • You are not allergic to the study medicines (Remimazolam or Esketamine).
  • Your body mass index (BMI) is 35 or lower.
  • You have not been in another clinical trial in the past 3 months.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07707258Recruiting
Remimazolam with oliceridine for sedation in older adults during GI endoscopy

This trial tests two medicines, remimazolam (a sedative) and oliceridine (a pain reliever), to see if they work well together for sedation during a painless gastrointestinal (GI) endoscopy in people aged 65 to 80. It aims to find a safe and effective option for older adults.

Shanghai, Shanghai Municipality
NCT06721195Recruiting
Study of Euphoria from Remimazolam During GI Scopes

This trial studies a sedative called remimazolam and how it makes people feel during routine upper and lower GI scope procedures. It may help doctors understand which patients are more likely to feel a sense of euphoria (a feeling of intense happiness) from the medicine.

Shanghai, Shanghai Municipality
NCT06777758Recruiting· Phase 4
Comparing two sedatives for endoscopy procedures

This trial compares two sedative medications, Remimazolam and Propofol, to see which works better for upper GI endoscopy exams and treatments. The goal is to help doctors choose the best option for patients.

Kaohsiung City
NCT07456111Recruiting· Phase 4
Comparing two sedatives for colonoscopy with polyp removal

This trial compares two sedative medications, remimazolam and propofol, to see which works better and is safer for people having a colonoscopy to remove polyps. It could help choose a sedation option with fewer side effects.

Zagreb
NCT07395596Recruiting· Phase 4
Remimazolam for Bronchoscopy in High-Risk Patients

This trial tests a sedative called remimazolam for people who are at higher risk during a painless bronchoscopy (a lung exam). It aims to see if this drug is safe and effective for you.

Hangzhou, Zhejiang
NCT06258356Not yet recruiting
Sedation drug comparison for high-risk ERCP patients

This trial tests a sedative called remimazolam for people with serious health conditions who need an ERCP, a procedure to examine the bile ducts. It aims to find a safer sedation option for those at higher risk.

Hear when a new Gastrointestinal Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.